Defective ristocetin-induced platelet aggregation in von Willebrand's disease and its correction by factor VIII
about
Studies on the mechanism of ristocetin-induced platelet agglutination. Effects of structural modification of ristocetin and vancomycinGlycoprotein IIb-IIIa-dependent aggregation by glycoprotein Ibalpha is reinforced by a Src family kinase inhibitor (PP1)-sensitive signalling pathwayUse of ristocetin cofactor activity in the management of von Willebrand disease.Platelet membrane glycoproteins implicated in ristocetin-induced aggregation. Studies of the proteins on platelets from patients with Bernard-Soulier syndrome and von Willebrand's disease.The effects of ristocetin and von Willebrand factor on platelet electrophoretic mobility.A murine monoclonal antibody that completely blocks the binding of fibrinogen to platelets produces a thrombasthenic-like state in normal platelets and binds to glycoproteins IIb and/or IIIaEditorial: The hemophiloid diseases and factor VIII. Clinical molecular biologyPlatelet receptors for human Factor VIII/von Willebrand protein: functional correlation of receptor occupancy and ristocetin-induced platelet aggregation.The platelet: life on the razor's edge between hemorrhage and thrombosis.von Willebrand factor binding to platelet GpIb initiates signals for platelet activation.Quantitative assay of a plasma factor deficient in von Willebrand's disease that is necessary for platelet aggregation. Relationship to factor VIII procoagulant activity and antigen contentAntihemophilic factor antigen. Localization in endothelial cells by immunofluorescent microscopy.Interaction of von Willebrand factor with human platelets in the plasma milieuEndothelial cell synthesis of von Willebrand antigen II, von Willebrand factor, and von Willebrand factor/von Willebrand antigen II complex.Interaction of asialo von Willebrand factor with glycoprotein Ib induces fibrinogen binding to the glycoprotein IIb/IIIa complex and mediates platelet aggregation.The interaction of bovine factor VIII with human plateletsStudies on human antihemophilic factor. Evidence for a covalently linked subunit structure.An inherited platelet function defect in Basset hounds.Electron microscopy of human factor VIII/Von Willebrand glycoprotein: effect of reducing reagents on structure and functionSurvival of 125iodine-labeled Factor VIII in normals and patients with classic hemophilia. Observations on the heterogeneity of human Factor VIII.Factor VIII/von Willebrand factor protein. Galactose a cryptic determinant of von Willebrand factor activity.Demonstration and characterization of specific binding sites for factor VIII/von Willebrand factor on human plateletsSome effects of calcium on the activation of human factor VIII/Von Willebrand factor protein by thrombinThe properties of immune complexes formed by human antibodies to factor VIII.von Willebrand's disease antigen II. A new plasma and platelet antigen deficient in severe von Willebrand's disease.Platelet hyperreactivity explains the bleeding abnormality and macrothrombocytopenia in a murine model of sitosterolemiaStructure of ristocetin A in complex with a bacterial cell-wall mimeticPlatelet interaction with von Willebrand factor is enhanced by shear-induced clustering of glycoprotein Ibα.Limitations of the ristocetin cofactor assay in measurement of von Willebrand factor function.Synthesis of von Willebrand factor by cultured human endothelial cells.Nature of von Willebrand factor: a new assay and a specific inhibitor.Inhibition of fibrinogen binding to stimulated human platelets by a monoclonal antibody.von Willebrand factor and platelet function.Difficulties and pitfalls in the laboratory diagnosis of bleeding disorders.The cytoplasmic domain of the alpha-subunit of glycoprotein (GP) Ib mediates attachment of the entire GP Ib-IX complex to the cytoskeleton and regulates von Willebrand factor-induced changes in cell morphology.Platelet-dependent von Willebrand factor activity. Nomenclature and methodology: communication from the SSC of the ISTH.Progress in Understanding the Genetic Information and Biosynthetic Pathways behind Amycolatopsis Antibiotics, with Implications for the Continued Discovery of Novel Drugs.History of Antibiotics Research.Total Syntheses of Vancomycin-Related Glycopeptide Antibiotics and Key Analogues.Technical considerations for platelet aggregation and related problems.
P2860
Q24595238-A76BB46C-3A27-4EA6-A8A1-6E222FF78458Q28344289-1F51D158-4EF3-49C6-873F-D59CA454BF35Q32154892-F202DDB0-AD48-4064-98EF-8B5D9E602B57Q33332522-C248AE8F-C130-4017-886B-074C9EFC2212Q33446108-761B50C5-4D94-4633-962B-AF165EE2480FQ33821916-91006089-5A2E-4376-8858-779496BC945AQ33823350-A3B23897-780A-420A-AC6F-CBC0F00C554DQ34039151-7681892C-44F2-46F0-872C-53D97DE97222Q34175105-99839ADE-F7EE-4195-884F-4707A8E997CEQ34208569-72942BAA-9593-4E34-9FE5-82C5F283214FQ34512731-DE4D0C4E-CE43-4E1D-8941-B82601C303FAQ34512963-D07D0E86-5772-4F21-8EED-72FE7E03AAD4Q34602783-79B05015-DDE4-4668-B1C2-FC151CE52DC4Q34624113-6D5387DC-E85F-4ADF-8619-76B2A8432814Q34624945-850093A1-020C-463E-94D9-4CF4928B9128Q35195700-9A39A9CB-0A34-4577-881D-7459FE298035Q35199709-FDC3F672-F922-422E-9182-231E2966FC5BQ35621515-EED83753-CD32-451A-9EEF-A67CCBD53D4FQ36209412-6EF9DF21-BE67-4229-AAA1-1B11D542BBBDQ37030290-E47D6845-8914-43B5-84EA-1EE86BB699DCQ37031115-3298A2C6-5BF9-4959-BD44-F206286E8868Q37037311-0D5739A4-FD55-4381-AABE-647278D8EC75Q37047369-BC67F429-873D-44D6-902A-2EE9C0647661Q37048262-4A033E05-E3A6-4263-B6CC-2E66B716AEC6Q37054131-408916DF-8300-4479-997A-68CB8EFB1FCEQ37226752-00C02E66-0BF7-4F9F-853C-3B070EBB402BQ37272334-257BF52A-4186-46C9-A1ED-24573097BB5AQ37273226-F5E146D4-5B1E-4264-9C0C-78307EEE2ACBQ37300927-8F952725-7267-4469-A8C2-4C4D2ACD8300Q37444356-580C26BD-B5D6-4407-8D73-C70D8BDECCEBQ37454132-19B9A6C3-FA6F-4FA6-BE0E-5B23934E41B6Q37609861-6544B3A9-4070-41FE-B1B4-B03E23B8CB16Q37711736-2AAD65BC-6784-46EB-8D37-0AB2E5548B90Q38020976-9D92C5F4-4B6E-4B6E-B9DA-632F1537F54EQ38357855-960BDFD3-CC19-4EC1-A1BA-D982853CEEA4Q38413638-E2CF5AA8-CA40-4EE6-B160-05E1190CE4FAQ38616773-8C228498-F5EC-4DE4-9602-3EDF33AAF58AQ38980021-ECAADF5B-E8B9-4183-884C-5A53AE793EFCQ39258608-B6E995A3-CA10-489E-8ADE-CE3C56361B8CQ40174830-23633207-45F5-4E90-8A18-2DF5C0D69721
P2860
Defective ristocetin-induced platelet aggregation in von Willebrand's disease and its correction by factor VIII
description
1973 nî lūn-bûn
@nan
1973 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1973 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1973年の論文
@ja
1973年論文
@yue
1973年論文
@zh-hant
1973年論文
@zh-hk
1973年論文
@zh-mo
1973年論文
@zh-tw
1973年论文
@wuu
name
Defective ristocetin-induced p ...... its correction by factor VIII
@ast
Defective ristocetin-induced p ...... its correction by factor VIII
@en
type
label
Defective ristocetin-induced p ...... its correction by factor VIII
@ast
Defective ristocetin-induced p ...... its correction by factor VIII
@en
prefLabel
Defective ristocetin-induced p ...... its correction by factor VIII
@ast
Defective ristocetin-induced p ...... its correction by factor VIII
@en
P2093
P2860
P356
P1476
Defective ristocetin-induced p ...... its correction by factor VIII
@en
P2093
P2860
P304
P356
10.1172/JCI107464
P407
P577
1973-11-01T00:00:00Z